Anna E. Vinkhuyzen is a geneticist based in Brisbane, QLD, Australia.
Genetics can affect how people grow, learn, move, and stay well. Anna’s work is mainly about helping patients and families make sense of health issues that can have a genetic link, even when things feel confusing at first.
Her clinical focus includes Hartnup disease, vitamin D deficiency, and a range of conditions where genetics and health needs can overlap. In many cases, vitamin D issues are not just about diet. They can connect to how the body processes certain nutrients, so looking at the bigger picture matters.
Anna also works with people dealing with motor neuron disease, including Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig’s disease). This is a tough diagnosis. At times, families want clear answers about what might be causing symptoms, and what options could help with day to day planning.
Another part of her work involves Autism Spectrum Disorder. Autism can look different from person to person, and support often needs to be practical. Anna focuses on helping explain what may be going on, and how genetic testing (when it fits) can add useful context.
She also looks at malnutrition, which can happen for many reasons. When nutrition is low, it can affect energy, growth, immunity, and overall health. Over time, Anna helps connect the dots between feeding, health history, and any underlying factors that might be worth checking.
In some cases, she supports people affected by schizophrenia. This can be hard to understand, especially when symptoms change over time. Genetics is only one piece of the puzzle, but it can help guide conversations about risk, care, and what to watch for.
Anna’s experience comes from working with real people and their support networks. She understands that no two cases are the same, and that families often need information they can actually use. Sessions are usually about clarity, not jargon. The aim is to help patients feel more informed about their health and next steps.
She is also mindful of how research can support clinical care. Where relevant, genetics findings and new evidence can help shape how information is shared and how future options are considered.